Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes-Reference-Cited by-同舟云学术

Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes

Published:2014-11 Issue:4 Volume:90 Page:819-827
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

McAvoy Sarah,Ciura Katherine,Wei Caimiao,Rineer Justin,Liao Zhongxing,Chang Joe Y.,Palmer Matthew B.,Cox James D.,Komaki Ritsuko,Gomez Daniel R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer;Blackstock;J Clin Oncol,2007

2. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence;Hung;Thorax,2009

3. Advances in cytotoxic chemotherapy for the treatment of metastatic or recurrent non-small cell lung cancer;Milton;Semin Oncol,2005

4. Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: A systematic review and practice guideline;Noble;J Thorac Oncol,2006

5. Palliative re-irradiation for in-field recurrence after definitive radiotherapy in patients with primary lung cancer;Ebara;Anticancer Res,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy;International Journal of Particle Therapy;2024-09

2. Interdisciplinary Approach Toward Reirradiation of Cancer Patients;Cureus;2024-07-30

3. Stereotactic Body Radiotherapy Reirradiation Is Safe in Patients With Lung Cancer With In-Field Enlarged Tumor Recurrence;Technology in Cancer Research & Treatment;2024-01

4. New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group;Critical Reviews in Oncology/Hematology;2023-10

5. A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy;Radiotherapy and Oncology;2023-08